Blood markers and frailty in older cancer surgery patients
This study looks at how certain blood markers (albumin/creatine ratio, vitamin B12, and folate) relate to frailty in older adults having surgery for stomach or intestinal cancer. The goal is to understand if these markers can help predict which patients may be more frail.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 65 years old or older.
- You must have a cancer in your stomach or intestines that is being removed with surgery.
- You must be in good to moderate health according to your anesthesia team (ASA risk group I, II, or III).
- This is not for emergency surgeries or if you choose not to take part.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how frailty, or overall physical weakness, affects recovery after surgery for gastrointestinal cancer in people aged 60 and older. The findings may help doctors better prepare patients for surgery and improve their recovery.
This study looks at “frailty,” or how well the body may handle stress, around the time of surgery in people age 65 and older. It may help doctors better understand who is at higher risk and how to plan care around surgery.
This trial looks at whether “frailty” (how weak or vulnerable someone is) changes short- and long-term outcomes after surgery. It may help doctors better predict who could benefit from extra support before and after surgery.
This trial studies simple “frailty” assessments (tests of strength, memory, and daily functioning) to better predict risk in people with gynecologic cancers who are planning or having surgery. If you qualify, the results may help doctors identify who needs extra support before and after surgery.
This study looks at frailty in older adults (70+) who are having an outpatient digestive endoscopy. It aims to understand how frailty affects the procedure and recovery.
This study looks at whether frailty (weakness and vulnerability) can help predict the risk of bleeding in older patients who have had a heart attack. The goal is to better identify who might need extra monitoring or different treatments to prevent dangerous bleeding.
Hear when a new Frailty trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.